Luca Del Prete

Dr. Luca Del Prete

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2020 in Gut
Verified
Journal Article
Open access
PDF file
CBChiara Becchetti
Chiara Becchetti
MZMarco Fabrizio Zambelli
Marco Fabrizio Zambelli
LPLuisa Pasulo
Luisa Pasulo
MDMaria Francesca Donato
Maria Francesca Donato
FIFederica Invernizzi
Federica Invernizzi
JDJean-François Dufour
Jean-François Dufour
Objective Knowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection. Design We conducted an international prospective study across Europe on liver transplant recipients with SARS-CoV-2 infection confirmed by microbiological assay during the first outbreak of COVID-19 pandemic. Baseline characteristics, clinical presentation, management of immunosuppressive therapy and outcomes were collected. Results 57 patients were included (70% male, median (IQR) age at diagnosis 65 (57–70) years). 21 (37%), 32 (56%) and 21 (37%) patients had one cardiovascular disease, arterial hypertension and diabetes mellitus, respectively. The most common symptoms were fever (79%), cough (55%), dyspnoea (46%), fatigue or myalgia (56%) and GI symptoms (33%). Immunosuppression was reduced in 22 recipients (37%) and discontinued in 4 (7%). With this regard, no impact on outcome was observed. Forty-one (72%) subjects were hospitalised and 11 (19%) developed acute respiratory distress syndrome. Overall, we estimated a case fatality rate of 12% (95% CI 5% to 24%), which increased to 17% (95% CI 7% to 32%) among hospitalised patients. Five out of the seven patients who died had a history of cancer. Conclusion In this European multicentre prospective study of liver transplant recipients, COVID-19 was associated with an overall and in-hospital fatality rate of 12% (95% CI 5% to 24%) and 17% (95% CI 7% to 32%), respectively. A history of cancer was more frequent in patients with poorer outcome.

28 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
DPDamiano Patrono
Damiano Patrono
LPLuca Del Prete
Luca Del Prete
JEJanina Eden
Janina Eden
PDPhilipp Dutkowski
Philipp Dutkowski
JGJames V. Guarrera
James V. Guarrera
RRRenato Romagnoli
Renato Romagnoli
Machine perfusion (MP) techniques, including hypothermic oxygenated perfusion (HOPE), normothermic perfusion (NMP), and normothermic regional perfusion (NRP), have emerged as strategies to optimize outcomes of extended criteria donor (ECD) livers. Despite increasing adoption, clinical indications remain uncertain. To assist transplant professionals in clinical decision making, a systematic review and meta-analysis was conducted according to PRISMA guidelines, including randomized controlled trials (RCT) and cohort studies. Outcomes of interest were ischemic cholangiopathy (IC) and graft survival. Moderator analyses explored the influence of donor, recipient, and procedural factors. Studies comparing different MP techniques and sequential approached were also reviewed qualitatively. HOPE was associated with a significant reduction in IC (RR 0.50; CI 0.31, 0.79; P = 0.003) and improved graft survival (RR 1.08; CI 1.05, 1.08; P < 0.001), with evidence supported by RCT. NMP did not significantly influence IC or graft survival. Based on retrospective studies, NRP significantly improved IC (RR 0.1, CI 0.05, 0.21; P < 0.0001) and graft survival (RR 1.11; CI 1.05, 1.17; P = 0.0001) as compared to super-rapid recovery in controlled donation after circulatory death (DCD). Sequential approaches showed promise in high-risk grafts but require further validation. Studies comparing different MP approaches are still limited. Available literature is largely heterogeneous regarding risk profile and characteristic on included donors, study designs and considered endpoints, limiting the possibility to provide clear recommendation about clinical indications. Further comparative trials and studies focusing on specific donor-recipient scenarios are necessary to refine MP utilization and optimize LT outcomes.

27 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
BMBianca Magro
Bianca Magro
DPDomenico Pinelli
Domenico Pinelli
MGMassimo De Giorgio
Massimo De Giorgio
MLMaria Grazia Lucà
Maria Grazia Lucà
AGArianna Ghirardi
Arianna Ghirardi
SFSTEFANO FAGIUOLI
STEFANO FAGIUOLI
Background and Aim: Hepatocellular carcinoma (HCC) recurrence rates after liver transplantation (LT) range between 8 and 20%. Alpha-fetoprotein (AFP) levels at transplant can predict HCC recurrence, however a defined cut-off value is needed to better stratify patients. The aim of this study was to evaluate the rate of HCC recurrence at our centre and to identify predictors, focusing on AFP. Methods: We retrospectively analysed 236 consecutive patients that were waitlisted for HCC who all met the Milan criteria from January 2001 to December 2017 at our liver transplant centre. A total of twenty-nine patients dropped out while they were waitlisted, and 207 patients were included in the final analysis. All survival analyses included the competing-risk model. Results: The mean age was 56.8 ± 6.8 years. A total of 14% were female (n = 29/207). The median MELD (model for end-stage liver disease) at LT was 12 (9–16). The median time on the waitlist was 92 (41–170) days. The HCC recurrence rate was 16.4% (n = 34/208). The mean time to recurrence was 3.3 ± 2.8 years. The median AFP levels at transplant were higher in patients with HCC recurrence (p < 0.001). At multivariate analysis, the AFP value at transplant that was greater than 25.5 ng/mL (AUC 0.69) was a strong predictor of HCC recurrence after LT [sHR 3.3 (1.6–6.81); p = 0.001]. The HCC cumulative incidence function (CIF) of recurrence at 10 years from LT was significantly higher in patients with AFP > 25.5 ng/mL [34.3% vs. 11.5% (p = 0.001)]. Moreover, an increase in AFP > 20.8%, was significantly associated with HCC recurrence (p = 0.034). Conclusions: In conclusion, in our retrospective study, the AFP level at transplant > 25.5 ng/mL and its increase greater than 20.8% on the waitlist were strong predictors of HCC recurrence after LT in a cohort of patients that were waitlisted within the Milan criteria. However further studies are needed to validate these data.

29 October 2024 in Updates in Surgery
Verified
Journal Article
Open access
PDF file
LPLuca Del Prete
Luca Del Prete
CQCristiano Quintini
Cristiano Quintini
TUTeresa Diago Uso
Teresa Diago Uso
Small-for-size syndrome poses a significant challenge in living donor liver transplantation, with potentially severe consequences including liver failure and death. This review explores the management strategies for SFSS, starting from the pathophysiology of the disease. SFSS arises from insufficient liver mass in the graft and hyperdynamic circulation in cirrhotic recipients, leading to portal hyperperfusion and subsequent liver injury. Risk factors include graft size, quality, recipient factors, and hemodynamic changes during transplantation. Hemodynamic monitoring is crucial during living donor liver transplantation to optimize portal vein and hepatic artery flow. Prevention strategies focus on donor-recipient matching and intraoperative graft inflow modulation. Optimizing venous outflow and avoiding portal hyperperfusion is essential. Management of established small-for-size syndrome involves supportive care, pharmacologic interventions, and radiological and surgical options. Pharmacotherapy includes somatostatin analogues, beta-blockers, and vasopressin analogues to reduce portal flow and pressure. Surgical interventions aim to modulate portal flow and mitigate complications. Retransplantation may be necessary in severe cases, guided by persistent graft dysfunction despite liver flow modulations. In conclusion, preventing and managing small-for-size syndrome in living donor liver transplantation requires comprehensive assessment and tailored interventions. Advancements in graft/recipient matching, hemodynamic monitoring, pharmacologic and surgical techniques aiming to inflow modulation have improved outcomes, enabling successful transplantation even with ultra-small grafts.

16 February 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
SCStefano Piero Bernardo Cioffi
Stefano Piero Bernardo Cioffi
OCOsvaldo Chiara
Osvaldo Chiara
LPLuca Del Prete
Luca Del Prete
ABAlessandro M. Bonomi
Alessandro M. Bonomi
Michele AltomareMichele Altomare
Michele Altomare
Stefania CimbanassiStefania Cimbanassi
Stefania Cimbanassi
Purpose: Complex enteric fistulas (CEF) represent general surgeons’ nightmare. This paper aims to explore the impact on failure-to-rescue (FTR) rate of a standardised and integrated surgical and critical care step-up approach. Methods: This was a retrospective observational cohort study. Patients treated for CEF from 2009 to 2019 at Niguarda Hospital were included. Each patient was approached following a three-step approach: study phase, sepsis control and strategy definition phase, and surgical rescue phase. Results: Sixteen patients were treated for CEF. Seven fistulas were classified as complex entero-cutaneous (ECF) and nine as entero-atmospheric fistula (EAF). Median number of surgical procedures for fistula control before definitive surgical attempt was 11 (IQR 2–33.5). The median time from culprit surgery and the first access at Niguarda Hospital to definitive surgical attempt were 279 days (IQR 231–409) and 120 days (IQR 34–231), respectively. Median ICU LOS was 71 days (IQR 28–101), and effective hospital LOS was 117 days, (IQR 69.5–188.8). Three patients (18.75%) experienced spontaneous fistula closure after conversion to simple ECF, whereas 13 (81.25%) underwent definitive surgery for fistula takedown. Surgical rescue was possible in nine patients. Nine patients underwent multiple postoperative revision for surgical complications. Four patients failed to be rescued. Conclusion: An integrated step-up rescue strategy is crucial to standardise the approach to CEF and go beyond the basic surgical rescue procedure. The definition of FTR is dependent from the examined population. CEF patients are a unique cluster of emergency general surgery patients who may need a tailored definition of FTR considering the burden of postoperative events influencing their outcome.

15 July 2025 in International Journal of Surgery
Verified
Journal Article
Open access
LPLuca Del Prete
Luca Del Prete
BCBeatrice Cazzaniga
Beatrice Cazzaniga
SAStephen Aniskevich
Stephen Aniskevich
VAVatche Agopian
Vatche Agopian
NSNatalie K. female Smith
Natalie K. female Smith
CQCristiano Quintini
Cristiano Quintini
Background: Intracardiac thrombosis (ICT) during liver transplantation (LT) is a rare but life-threatening complication with limited data regarding its risk factors, management, and outcomes. This study aimed to identify factors associated with ICT development, define predictors of intraoperative outcomes, and propose a novel classification and management algorithm for ICT. Methods: A multicenter, international retrospective case-control study was conducted on liver transplant recipients from seven centers between January 2005 and December 2023. ICT cases were identified through transesophageal echocardiography (TEE) or autopsy and matched 1:1 with controls. Results: Among 11 077 liver transplant recipients screened, 133 patients (1.2%) developed ICT. ICT occurred predominantly after reperfusion (58%). Compared to controls, ICT cases exhibited higher preoperative international normalized ratio ( P = 0.001) and fibrinogen levels ( P = 0.014). Post-reperfusion syndrome ( P < 0.001), disseminated intravascular coagulation ( P < 0.001), and primary graft failure ( P = 0.002) were also more common in the ICT group. Continuous veno-venous hemofiltration during surgery (odds ratio [OR] 8.20, 95% confidence interval [CI]: 2.09–38.1; P = 0.004) was associated with ICT development. ICT was associated with markedly higher rates of cardiac arrest ( P < 0.001) and intraoperative mortality ( P < 0.001), with thrombus location in the left heart chambers representing a significant predictor of mortality (OR 20.7, 95% CI: 6.25–81.3; P < 0.001). ICT grades 2 and 3 were associated with a markedly increased risk of intraoperative cardiac arrest ( P < 0.05). Importantly, delayed use of TEE was strongly associated with intraoperative death (OR 6.27, 95% CI: 1.45–27.1; P = 0.014). The 90-day mortality was 43% in ICT cases compared to 4.5% in controls, while 1-year mortality was 46% versus 10.5%, respectively. Conclusions: ICT during LT is a rare but severe complication associated with intraoperative mortality and poor short-term survival. Coagulation profile and intraoperative management play critical roles in ICT development. The early use of TEE enables timely diagnosis and intervention, improving patient outcomes. We propose a novel ICT classification offering a systematic framework for risk stratification and management to mitigate progression and mortality.